Premium
Potential for drug interactions involving cytochrome P450 in patients attending palliative day care centres: a multicentre audit
Author(s) -
Wilcock A.,
Thomas J.,
Frisby J.,
Webster M.,
Keeley V.,
Finn G.,
Fossey K.,
Wee B.,
Beale J.,
Lennard M. S.
Publication year - 2005
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.2005.02428.x
Subject(s) - medicine , drug , drug interaction , palliative care , drug drug interaction , cytochrome p450 , audit , pharmacokinetics , pharmacology , intensive care medicine , nursing , management , metabolism , economics
Aim To determine the potential for drug interactions involving cytochrome P450 (CYP) in patients receiving palliative day care. Methods Drugs used by patients attending four specialist palliative day care centres were reviewed to identify combinations that could result in a pharmacokinetic interaction via any of the five main human forms of CYP. Results Of 160 patients, 145 (91%) were prescribed at least one drug that was a substrate, inhibitor or inducer of one of the five main CYP isoforms. Twenty‐four drug combinations, involving 34 patients, could have given rise to a clinically important interaction. Conclusions Prescribers should be aware that in this group of patients, one in five are at risk of a clinically important CYP‐mediated drug interaction.